Evaluate the full impact of TD, including negative effects on physical, psychosocial, and occupational functioning, psychiatric treatment, and QoL Implement strategies for the timely diagnosis and assessment of TD across the spectrum, using standardized instruments, including the IMPACT-TD scale and the AIMS Assess the mechanisms of action of FDA-approved VMAT-2 inhibitors versus anticholinergics, pharmacokinetic differences between VMAT-2 inhibitors, and clinical trial data associated with their safety, tolerability, and efficacy for patients with TD Compare the available formulations, dosing requirements, and drug interactions of VMAT-2 inhibitors for TD, with implications for treatment selection and titration
- Provider:HMP Education
- Activity Link: https://www.hmpeducation.com/program/24-uspcr-101-3
- Start Date: 2024-10-22 05:00:00
- End Date: 2024-10-22 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours
Psychology: 1.0 hours
Social Work: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: neurocrine biosciences - Amount: 0 - Is Kind Support: False Source: Teva Pharmaceutical Industries - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest